Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes

By Wysham Carol   Lush Cameron   Zhang Bei   Maier Holly   Wilhelm Ken  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 79-85

Informa Healthcare

Access to resources Recommend Favorite

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 9, 2015-09 ,pp. : 904-907

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 956-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 10, 2015-10 ,pp. : 956-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

By Scalone Luciana   Mantovani Lorenzo G.   Krol Marieke   Rofail Diana   Ravera Simona   Grazia Bisconte Maria   Borgna-Pignatti Caterina   Borsellino Zelia   Cianciulli Paolo   Gallisai Domenico   Prossomariti Luciano   Stefàno Ippazio   Cappellini Maria D.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1905-1917

Informa Healthcare

Access to resources Recommend Favorite